NASDAQ:FOLD

Amicus Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy FOLD

*Your capital is at risk

$14.49

+0 (+0%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

FOLD Prediction Chart

FOLD Predictions History

Latest community submissions for FOLD.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	May 3, 2017	$7.58 +1.34%	$7.48	X	98.70%	1
E.Nessim.Roman.4816	May 3, 2017	$7.80 +4.28%	$7.48	X	95.70%	0
JuanC Villegas Pro	May 3, 2017	$7.78 +4.01%	$7.48	X	96.00%	0
brian @brian.2828	Feb 10, 2017	$7.10 +14.52%	$6.20	X	85.50%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for FOLD with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT AMICUS THERAPEUTICS

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by